0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 763000 results.
Recombinant human interferon α2b is a type of protein-based therapeutic product that belongs to the interferon family. It is produced using...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global CD20 Target Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Hematologic Malignancies Treatment market size was valued at USD 55000 million in 2023 and is forecast to a readjusted size of USD 221510...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global BTK Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it is expected to grow at a...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Dasatinib is a selective tyrosine kinase receptor inhibitor that is used in the therapy of chronic myelogenous leukemia (CML) positive for the...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Erwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Midostaurin is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML),...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Bruton Tyrosine Kinase (BTK) Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
